China’s annual trade surplus hits a record $1.2 trillion as December exports sharply beat estimates

China’s annual trade surplus hits a record .2 trillion as December exports sharply beat estimates


QINGDAO, CHINA – JANUARY 13, 2026 – The cargo ship is loading and unloading foreign trade containers at Qingdao Port in Qingdao City, Shandong Province, China on January 13, 2026.

Cfoto | Future Publishing | Getty Images

China’s exports growth in December sharply beat expectations, catapulting the annual trade surplus to a record high, even as imports rose at their fastest pace in three months.

Exports surged 6.6% in U.S. dollar terms last month from a year earlier, Chinese customs data showed Wednesday, topping analysts’ median estimate for a 3% growth and accelerating from a 5.9% jump in November.

Imports rose 5.7% in December from a year earlier, topping expectations for a 0.9% growth — strongest since September last year when they rose 7.4%, according to LSEG data.

China’s exports for the full year grew 5.5% compared to 2024 while imports stayed flat, taking Beijing’s trade surplus to $1.19 trillion.

Trade tensions with the U.S. have led to double-digit declines in Chinese shipment to the country for most part of last year.

As Chinese exporters have ramped up shipments to non-U.S. markets, the growing trade imbalance has prompted concerns from major trading partners, including the European Union.

International Monetary Fund Managing Director Kristalina Georgieva in a December press conference urged Beijing to shift away from relying on exports for growth and accelerate its push to boost domestic consumption.

Chinese officials had pledged to expand imports and work toward balancing trade.

Zhiwei Zhang, president and chief economist at Pinpoint Asset Management, expects Beijing to keep the macro policy stance unchanged at least in the first quarter, as strong export growth helps mitigate soft domestic demand and trade tensions with the U.S. have eased.

China and U.S. in October agreed to roll back a series of export-control measures and higher tariffs in a 1-year trade truce, following a meeting between Chinese President Xi Jinping and his American counterpart Donald Trump.

While overall exports saw robust growth in 2025, trade tensions with the U.S. had led to double-digit declines in Chinese shipment to the country for most part of last year.

China is set to release next Monday its annual and fourth-quarter gross domestic product data. Economists polled by Reuters expected the world’s second largest economy to have expanded 4.5% in the final quarter. Beijing had set it growth target for 2025 at around 5%.

The nearly $19 trillion economy has struggled to shake off deflationary pressure as a deepening real estate collapse has weighed on household demand and a weak job market has clouded consumer confidence. Consumer prices in the country stayed flat in 2025, missing the official target of around 2% increase.

This is breaking news. Please refresh for updates.



Source

We spoke to over 30 CEOs and business leaders. Here’s what worries them most
World

We spoke to over 30 CEOs and business leaders. Here’s what worries them most

Business leaders are confronting a new operating reality: one where war, inflation, AI and supply chain shocks are no longer exceptional events, but part of the baseline. CNBC spoke to more than 30 CEOs, business executives and industry leaders at the annual Converge Live event in Singapore last week. Across sectors — banking, energy, shipping, […]

Read More
U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets
World

U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets

A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 16, 2026. Jeenah Moon | Reuters Global markets are entering the week balancing resilient risk appetite against renewed geopolitical strain as prospects of U.S.-Iran negotiations took a hit over the weekend. U.S. President Donald Trump scrapped […]

Read More
Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in .75 billion deal
World

Sun Pharma shares jump 5% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

SHANGHAI, CHINA – NOVEMBER 05: People visit the booth of Organon during the 7th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November 5, 2024 in Shanghai, China. The 7th China International Import Expo (CIIE) kicked off in Shanghai on November 5. (Photo by Tang Yanjun/China News Service/VCG via […]

Read More